
|Articles|March 15, 2002
Find out how viscoadaptive behaves differently for successful phaco
Dorado, Puerto Rico-Healon 5 (Pharmacia) can be used routinely during cataract surgery once the surgeon understands how it differs from other viscoelastic agents, reported Roger Steinert, MD, at the Current Concepts in Ophthalmology meeting sponsored by Johns Hopkins University of Medicine.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocumetics reports first-in-human data investigational accommodating IOL in severe vision loss
2
Metformin use associated with reduced incidence of intermediate AMD
3
EnVision Summit 2026: Ultimate gathering place for ophthalmic education
4
Noninvasive LED light therapy shows long-term safety in early cataract clinical follow-up
5




























